Sun Sentinel Palm Beach Edition

High price for growing industry

Pot companies face financial hurdles to establish businesses

- By Austin Fuller

Last fall, as California­based marijuana retailer MedMen was opening new facilities in Florida and pumping millions of dollars into a state initiative to legalize recreation­al marijuana, the company also announced it would lay off 190 people.

MedMen reported a net loss of $277 million for the financial year that ended in summer 2019, as it prepared to open a store on Internatio­nal Drive and ready a facility in Eustis, northwest of Orlando, to produce more products such as lotions and vaporizers.

“Every emerging, brand new industry is sort of who’s first in has to learn all the hard lessons,” said Nick Hansen, MedMen’s vice president of government affairs. “So I think everybody in Florida and really across the country is learning sort of the hard lessons.”

As companies stormed into Florida since 2016 when the state legalized medical marijuana, some of their recent earnings reports dispel any notion that the pot business is easy money as the number of patients grows by thousands each week. At last count, more than 317,000 people were eligible to use the drug for medical reasons.

Four of the five companies with the most dispensari­es in Florida are publicly traded — Trulieve, Curaleaf, Liberty Health Sciences and Fluent — and two reported net losses in recent earnings reports.

Curaleaf, based in Massachuse­tts, reported a net loss of $7.4 million for the third quarter of 2019. The company operating under the Fluent brand, which used to be known as Knox Medical and is headquarte­red in Miami, reported a net loss of $11.3 million in the third quarter of 2019.

Growing patients, growing dispensari­es

MedMen opened eight dispensari­es in Florida since last year and had plans to open more, including near the University of Central Florida. The company is reviewing its footprint in the state to determine the timing for opening additional dispensari­es, according to an earnings report.

“All of these people, all of these hard assets, and the plant itself it takes a lot of money to grow, and you’re building it from the ground up,” Hansen said. “You’re also building something for the future. You’re building something for an expected larger market space, and you are talking about a product that’s only been legalized in less than half of the states for less than three years.”

Florida is a part of that plan, he said.

“We have a lot invested [in Florida]; No. 1, we see a lot of potential here,” Hansen said. “We continue to grow month over month with our medical patients.”

There were 317,106 qualified patients in the state as of the Feb. 21 Office of Medical Marijuana Use report, up from 314,234 just the week before and 188,240 from about a year ago.

MedMen’s openings were just a slice of the new dispensari­es in the state. This time last year, the number of approved dispensing locations had just broken 100, and now there are more than 230 in Florida, state records show.

Florida-based Trulieve has the most, with 45 dispensing locations, and also leads the pack by dispensing more than 48 million milligrams of medical marijuana for the week of Feb. 14 through Feb. 20, according to the state’s Office of Medical Marijuana Use.

Trulieve reported $60.3 million in net income in the third quarter of 2019, $57.5 million in the second quarter and $14.7 million in the first quarter, earnings reports show. CEO Kim Rivers said the company has been focused on serving patients, “providing access across the state and doing that in a fiscally responsibl­e way.”

Surterra Wellness, which recently changed its corporate name to Parallel, and Curaleaf were the next two largest companies in terms of the number of dispensari­es in the state.

Parallel is not publicly traded and had 39 dispensing locations as

of Feb. 21. Its headquarte­rs are in Atlanta.

“The industry is growing, and as with any other start-up, it has to ‘storm, form and norm,’ ” Elizabeth Conway, Parallel’s Florida President said in an emailed response to questions sent through a spokespers­on. “Compliance in a highly regulated environmen­t, fiscal controls, patient access, great products, and stellar customer experience­s all cost money. Growing a business in the cannabis industry requires skilled management and financial discipline, both of which Parallel is fortunate to have.”

Curaleaf, with a presence in 14 states, had 28 Florida dispensing locations. It reported a net loss of $7.4 million for the third quarter of 2019, $24.4 million for the second quarter and $10.9 million for the first quarter, earnings reports show.

Cansortium, which operates under the Fluent brand with 19 Florida dispensari­es, reported a net loss of $33.1 million for nine months through the end of September, an earnings report shows.

Liberty Health Sciences, with 23 dispensari­es in Florida, reported a net income of $26.57 million in Canadian dollars for the nine months that ended Nov. 30, 2019, an improvemen­t over an about $18.48 million loss for the same period the year before.

‘You’re a retailer and you’re a farmer’

Medical marijuana companies in Florida must grow and produce their products from start to finish. MedMen’s offerings come from a facility in Eustis.

“In Florida, you’re a retailer, and you’re a farmer, and you’re everything in between, and that’s incredibly expensive,” Hansen said.

For Curaleaf, the challenge is maintainin­g a supply that keeps up with the growing number of patients, said Arizmendi-Kalb. It has growing and production facilities in South Florida, as well as a growing site in Mount Dora.

The company is building more capacity at its Mount Dora facility and has plans for another processing site in Lake Mary, Arizmendi-Kalb said.

Adding supply will help grow sales, he explained. And opening more stores will also drive revenue because patients in more neighborho­ods will have access to a nearby outlet.

Curaleaf has 12 more Florida dispensari­es in the pipeline, which will bring their total to 40, Arizmendi-Kalb said.

Parallel, Liberty Health Sciences and Trulieve also plan to grow.

“The Florida industry is one of the most exciting markets in the country,” Trulieve’s Rivers said.

 ?? RICARDO RAMIREZ BUXEDA/ORLANDO SENTINEL PHOTOS ?? Nick Hansen, who serves as MedMen’s vice president of government affairs, stands at the company’s Orlando dispensary on Internatio­nal Drive.
RICARDO RAMIREZ BUXEDA/ORLANDO SENTINEL PHOTOS Nick Hansen, who serves as MedMen’s vice president of government affairs, stands at the company’s Orlando dispensary on Internatio­nal Drive.
 ??  ?? Hansen shows off the company’s products. “We have a lot invested [in Florida]; No. 1, we see a lot of potential here,” he said.
Hansen shows off the company’s products. “We have a lot invested [in Florida]; No. 1, we see a lot of potential here,” he said.

Newspapers in English

Newspapers from United States